1)  factor V deficiency
因子V缺乏
2)  Factor V deficiency
凝血因子V缺乏
3)  factor
因子
1.
Study on the Relationship of Assessment Methods and Factors in the assessment of Eutrophication Lakes;
湖泊富营养化评价中的评价方法与因子关系的分析研究
2.
Study on the influential factors of the water quality in Chaohu Lake based on principal component analysis;
基于主成分分析的巢湖水质影响因子研究
3.
Effects of partial factors on hydrogen production by fermentative hydrogen-producing bacterial strain B49;
影响产氢发酵细菌B49产氢的部分因子研究
4)  Factor Ⅷ
因子Ⅷ
1.
Objective To evaluate the pathophysiological role of coagulation factor Ⅶ clotting activity (FⅦ:C),coagulation factor Ⅷ clotting activity (FⅧ:C) and fibrinogen (Fg) in patients with coronary heart disease (CHD);to study the relationship among them and co-relation with other cardiovascular risk factors;and to explore its potential clinical significance.
目的通过检测血浆中凝血因子Ⅶ促凝活性(FⅦ:C)、凝血因子Ⅷ促凝活性(FⅧ:C)及纤维蛋白原(Fg)水平来研究三者与冠状动脉性心脏病(CHD)的关系、并初步探讨冠心病患者血浆中三者间以及与其他心血管危险因子的相关性及潜在临床意义。
2.
Method Growth number, growth cycle phase, and the characteristics of endothelial cells(factor Ⅷ related antigen) of PAEC were investigated during hypoxia using the PAEC cultured in vitro as a model.
因子Ⅷ相关抗原 (ⅧR :Ag)阳性细胞数在缺氧过程中均呈明显下降 (P <0 。
5)  Factor Ⅶa
因子Ⅶa
6)  factor Ⅶ
因子Ⅶ
1.
Factor Ⅶ detection and its association with lipid in ischaemic heart disease;
缺血性心脏病患者血浆凝血因子Ⅶ与血脂的关系
2.
Objective:To investigate the correlation between GHbA1c and plasma factor Ⅶ clotting(FⅦc) activity,tissue-type plasminogen activator(T-PA) activity,plasminogen activator inhibitor-1(PAI-1) activity in type 2 diabetic patients with different types of coronary heart disease(CHD).
目的:研究冠心病合并2型糖尿病患者糖化血红蛋白(GHbA1c)与血浆凝血因子Ⅶc、组织型纤溶酶原激活剂(T-PA)及其抑制物-1(PAI-1)活性的相关性。
3.
Objective To evaluate the pathophysiological role of coagulation factor Ⅶ clotting activity (FⅦ:C),coagulation factor Ⅷ clotting activity (FⅧ:C) and fibrinogen (Fg) in patients with coronary heart disease (CHD);to study the relationship among them and co-relation with other cardiovascular risk factors;and to explore its potential clinical significance.
目的通过检测血浆中凝血因子Ⅶ促凝活性(FⅦ:C)、凝血因子Ⅷ促凝活性(FⅧ:C)及纤维蛋白原(Fg)水平来研究三者与冠状动脉性心脏病(CHD)的关系、并初步探讨冠心病患者血浆中三者间以及与其他心血管危险因子的相关性及潜在临床意义。
参考词条
补充资料:正常人白细胞转移因子 , 白细胞转移因子,转移因子
药物名称:转移因子

英文名:Transfer Factor

别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子
外文名:Transfer Factor ,TF
适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。
临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。
用量用法:
一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。
规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000.
注:严禁静脉给药.



类别:免疫调节剂
说明:补充资料仅用于学习参考,请勿用于其它任何用途。